IBM’s Watson group has invested an undisclosed amount of money in Pathway Genomics to help the company deliver an app that gives personalized advice to users based on their genetic information, as well as data collected by wearable devices, medical records and other sources. Like all Watson-powered apps, users will query the new app, called Panorama, using natural language and results are delivered based on analysis from sources including medical literature and clinical trials. So far, IBM has invested in a handful of companies building apps on Watson, including in the retail and health care spaces.
Advertisement
going slowly towards the end of the company. But Watson, IBM could revolutionize the management of semantics which is currently lacking treatment ‘Analytics’ and take the lead on a niche again.